Abstract:Encapsulation devices are an emerging barrier technology designed to prevent the immunorejection of replacement cells in regenerative therapies for intractable diseases. However, traditional polymers used in current devices are poor substrates for cell attachment and induce fibrosis upon implantation, impacting long-term therapeutic cell viability. Bioactivation of polymer surfaces improves local host responses to materials, and here we make the first step toward demonstrating the utility of this approach to improve cell survival within encapsulation implants. Using therapeutic islet cells as an exemplar cell therapy, we show that internal surface coatings improve islet cell attachment and viability, while distinct external coatings modulate local foreign body responses. Using plasma surface functionalization (plasma immersion ion implantation (PIII)), we employ hollow fiber semiporous poly(ether sulfone) (PES) encapsulation membranes and coat the internal surfaces with the extracellular matrix protein fibronectin (FN) to enhance islet cell attachment. Separately, the external fiber surface is coated with the anti-inflammatory cytokine interleukin-4 (IL-4) to polarize local macrophages to an M2 (anti-inflammatory) phenotype, muting the fibrotic response. To demonstrate the power of our approach, bioluminescent murine islet cells were loaded into dual FN/IL-4-coated fibers and evaluated in a mouse back model for 14 days. Dual FN/IL-4 fibers showed striking reductions in immune cell accumulation and elevated levels of the M2 macrophage phenotype, consistent with the suppression of fibrotic encapsulation and enhanced angiogenesis. These changes led to markedly enhanced islet cell survival and importantly to functional integration of the implant with the host vasculature. Dual FN/IL-4 surface coatings drive multifaceted improvements in islet cell survival and function, with significant implications for improving clinical translation of therapeutic cell-containing macroencapsulation implants.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c20096?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c20096</a>.Surface chemistry analysis of PES fibers following PIII treatment (Figure S1); in vitro validation of external IL-4 coating bioactivity using qPCR analysis of RAW 264.7 macrophages of classical M2 phenotype genes (Figure S2); in vitro comparison of whole islets vs dispersed islets/cells on treated PES (Figure S3); in vivo analysis of local immunomodulatory effects and comprehensive analysis of the nature of the immune microenvironment (Figure S4); and in vivo analysis of local angiogenesis (Figure S5) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c20096/suppl_file/am0c20096_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Cell Type-Specific Anti-Adhesion Properties of Peritoneal Cell Treatment with Plasma-Activated Media (PAM)

Effect of “phase Change” Complex on Postoperative Adhesion Prevention

Human tissue-resident peritoneal macrophages reveal resistance towards oxidative cell stress induced by non-invasive physical plasma

Melt Electrowriting-Printed Peritoneal Scaffold Prevents Peritoneal Adhesion and Facilitates Peritoneal Repair

Bioactivation of Encapsulation Membranes Reduces Fibrosis and Enhances Cell Survival

Adipose Mesenchymal Stem Cell-Derived Exosomes Relieve Postoperative Abdominal Adhesion By Activating the MAPK-ERK 1/2 and PI3K-Akt Pathways

The Therapeutic Potential of Targeting key signaling Pathways as a Novel Approach to Ameliorating Post-Surgical Adhesions

Post-surgical adhesions are triggered by calcium-dependent membrane bridges between mesothelial surfaces

Smart hydrogels delivered by high pressure aerosolization can prevent peritoneal adhesions

Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Promote Peritoneal Healing by Activating MAPK-ERK1/2 and PI3K-Akt to Alleviate Postoperative Abdominal Adhesion

A combination of hybrid polydopamine-human keratinocyte growth factor nanoparticles and sodium hyaluronate for the efficient prevention of postoperative abdominal adhesion formation

Membrane-binding adhesive particulates enhance the viability and paracrine function of mesenchymal cells for cell-based therapy.

Human mesenchymal stromal cell adhesion and expansion on fluoropolymer surfaces modified with oxygen and nitrogen-rich plasma polymers

A review of physiological and cellular mechanisms underlying fibrotic postoperative adhesion

Molecular Characterization of Postoperative Adhesions: The Adhesion Phenotype

GelMA and Aliphatic Polyesters Janus Nanofibrous Membrane with Lubrication/anti-Fibroblast Barrier Functions for Abdominal Adhesion Prevention

Mesothelial cells and peritoneal homeostasis

Combined treatment of xyloglucan derivative hydrogel and anti-C5a receptor antibody in preventing peritoneal adhesion

Dipyridamole-Grafted Copolymer Electrospun Nanofiber Membranes for Suppression of Peritendinous Adhesions

Techniques for navigating postsurgical adhesions: Insights into mechanisms and future directions